Lupin Limited — Cefixime Exporter Profile
Indian Pharmaceutical Exporter · #2 for Cefixime · $4.2M export value · DGFT Verified
Lupin Limited is the #2 Indian exporter of Cefixime with $4.2M in export value and 83 verified shipments. Lupin Limited holds a 2.4% market share in Cefixime exports across 4 countries. The company exports 38 pharmaceutical products worth $271.4M across 19 therapeutic categories.
Lupin Limited — Cefixime Export Profile: Buyers & Destinations
Where Does Lupin Limited Export Cefixime?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $1.7M | 45 | 60.1% |
| MALAYSIA | $812.3K | 28 | 28.2% |
| MYANMAR | $300.8K | 8 | 10.4% |
| YEMEN, DEMOCRATIC | $37.0K | 2 | 1.3% |
Lupin Limited exports Cefixime to 4 countries. The largest destination is UNITED STATES accounting for 60.1% of Lupin Limited's Cefixime shipments, followed by MALAYSIA (28.2%) and MYANMAR (10.4%). These destinations reflect Lupin Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Cefixime from Lupin Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| UPS SUPPLY CHAIN SOLUTIONS | UNITED STATES | $1.7M | 45 |
| MYIT MAHAR TRADING CO., LTD | MYANMAR | $217.8K | 6 |
| BIOCARE PHARMACEUTICAL M SDN | MALAYSIA | $162.7K | 4 |
| TO THE ORDER | MALAYSIA | $48.0K | 3 |
| PJCC JALAN PJS | MALAYSIA | $47.6K | 1 |
| MYIT MAHAR TRADING CO.LTD | MYANMAR | $41.8K | 1 |
| MYIT MAHAR TRADING CO. LIMITED | MYANMAR | $41.3K | 1 |
| YEMEN KUWAIT BANK | YEMEN, DEMOCRATIC | $37.0K | 2 |
| JALAN PJS | MALAYSIA | $28.0K | 1 |
Lupin Limited supplies Cefixime to 9 buyers globally. The largest buyer is UPS SUPPLY CHAIN SOLUTIONS (UNITED STATES), followed by MYIT MAHAR TRADING CO., LTD (MYANMAR) and BIOCARE PHARMACEUTICAL M SDN (MALAYSIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Cefixime Export Value and How Much Does Lupin Limited Contribute?
India exported $61.9M worth of Cefixime through 8,398 shipments from 668 suppliers to 131 countries, serving 1,805 buyers globally. Lupin Limited contributes $4.2M to this total, accounting for 2.4% of India's Cefixime exports. Lupin Limited ships Cefixime to 4 countries through 9 buyers.
What Is the Average Shipment Value for Lupin Limited's Cefixime Exports?
Lupin Limited's average Cefixime shipment value is $50.0K per consignment, based on 83 shipments totaling $4.2M. The largest destination is UNITED STATES (60.1% of Lupin Limited's Cefixime exports).
How Does Lupin Limited Compare to Other Indian Cefixime Exporters?
Lupin Limited ranks #2 among 668 Indian Cefixime exporters with a 2.4% market share. The top 3 exporters are MICRO LABS LIMITED ($19.1M), AUROBINDO PHARMA LTD ($8.0M), SAKAR HEALTHCARE LIMITED ($4.5M). Lupin Limited processed 83 shipments to 4 destination countries.
What Cefixime Formulations Does Lupin Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| IXIME 400MG (1X6T)-MEGA-DMF CEFIXIME TABLETS USP OTHERS-CEPHALOSPORIN (17970 BOX)(CIN NO. L24100MH1983PLC029442) | $107.1K | 3 |
| CEFIXIME CAPS 400MG 10S BLISTER USA (CEF | $96.6K | 2 |
| CEFIXIME CAPSULES 400MG USA (CEFIXIME 40 | $93.6K | 2 |
| CEFIXIME CAPS 400MG 50'S USA CEFIXIME C | $88.0K | 2 |
| IXIME 400MG (1X6T) - MEGA -DMF Cefixime | $50.0K | 1 |
| CEFIXIME CAPSULES 400MG (USA) (CEFIXIME | $50.0K | 1 |
| CEFIXIME CAPSULES 400MG USA CEFIXIME 400MG 1 BTL x 50 CAPS | $50.0K | 1 |
| CEFIXIME CAPSULES 400MG 10S BLISTER USA | $50.0K | 1 |
| CEFIXIME FOS USP 200MG/5ML USCEFIXIMEFOR ORAL SUSPENSION USP 200MG/5ML - 3360 BTL x 50ML | $50.0K | 1 |
| CEFIXIME CAPSULES 400MG USA CEFIXIME 400MG- 2208 BTL x 50 CAPS | $50.0K | 1 |
Lupin Limited exports 66 distinct Cefixime formulations including tablets, capsules, syrups, and combination drugs. The top formulation is IXIME 400MG (1X6T)-MEGA-DMF CEFIXIME TABLETS USP OTHERS-CEPH with 3 shipments worth $107.1K.
Regulatory Requirements: Exporting Cefixime to Key Markets
What Lupin Limited must comply with to export Cefixime to its top destination countries
United States — FDA
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Lupin Limited Compare to Nearest Cefixime Exporters?
Exporters ranked immediately above and below #2 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 5 | SAKAR HEALTHCARE LIMITED | $4.5M | 91 | 11 | $50.0K |
| 8 | NECTAR LIFE SCIENCES LIMITED | $4.4M | 184 | 19 | $23.7K |
| 2 | LUPIN LIMITED ★ | $4.2M | 83 | 4 | $50.0K |
| 9 | CAPLIN POINT LABORATORIES LIMITED | $3.5M | 98 | 8 | $35.5K |
| 10 | MACLEODS PHARMACEUTICALS LTD | $3.3M | 65 | 9 | $50.0K |
Lupin Limited ranks #2 among 668 Indian Cefixime exporters. Average shipment value of $50.0K compared to the market average of $92.6K. The closest competitors by value are SAKAR HEALTHCARE LIMITED and NECTAR LIFE SCIENCES LIMITED.
Which Indian Ports Ship Cefixime Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 924 | 11.0% |
| JNPT | 498 | 5.9% |
| JNPT/ NHAVA SHEVA SEA | 480 | 5.7% |
| SAHAR AIR CARGO ACC (INBOM4) | 449 | 5.3% |
| SAHAR AIR | 412 | 4.9% |
| DELHI AIR CARGO ACC (INDEL4) | 399 | 4.8% |
| DELHI AIR | 366 | 4.4% |
| AHEMDABAD ICD | 226 | 2.7% |
What Other Advanced Antibiotics Products Does Lupin Limited Export?
Lupin Limited also exports these advanced antibiotics products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Lupin Limited's Cefixime Exports
Lupin's export operations are influenced by various geopolitical factors. The ongoing Israel-Iran tensions have led to increased security risks in the Red Sea, prompting major shipping lines to implement 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU, thereby escalating shipping costs for Indian exporters. (sgexports.odoo.com) Additionally, the 2025 United States–India diplomatic and trade crisis resulted in the U.S. imposing a 50% tariff on Indian exports, significantly affecting the competitiveness of Indian pharmaceutical products in the U.S. market. (en.wikipedia.org)
Conversely, the European Union's implementation of the Carbon Border Adjustment Mechanism (CBAM) poses compliance challenges for Indian exporters, including Lupin, necessitating adherence to stringent carbon reporting requirements. However, the EU's focus on reducing dependency on Chinese pharmaceutical imports presents an opportunity for Indian companies to capture a larger share of the European market.
Lupin Limited — Regulatory Compliance & Quality Standards
Maintaining stringent quality standards is paramount for Lupin's global operations. In February 2025, the U.S. FDA completed a Pre-Approval Inspection at Lupin's Somerset, New Jersey facility with zero observations, reflecting the company's commitment to compliance and quality. (lupin.com) However, the evolving regulatory landscape, including the EU's falsified medicines directive and the U.S. FDA's increasing scrutiny, necessitates continuous investment in quality assurance and regulatory compliance to ensure uninterrupted market access.
About Lupin Limited
Lupin Limited exports 38 products worth $271.4M. Beyond Cefixime, top products include Isoniazid, Cephalexin, Simvastatin, Rifampicin, Amlodipine. View the complete Lupin Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Cefixime — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Cefixime shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Lupin Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 83 individual customs records matching Lupin Limited exporting Cefixime, covering 66 formulations to 4 countries via 9 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 131+ countries, 1,805+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Cefixime Export Data from Lupin Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Lupin Limited's Cefixime exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Lupin Limited
Full Company Profile →
38 products · $271.4M total trade · 19 categories
Cefixime Stats
Company Overview
Top Products by Lupin Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Lupin Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Cefixime. For current shipment-level data, contact TransData Nexus.